Skip to main content
LNA Santé logo

LNA Santé — Investor Relations & Filings

Ticker · LNA ISIN · FR0004170017 LEI · 969500FULTKJYIRIAT87 PA Human health and social work activities
Open in API
Filings indexed 557 across all filing types
Latest filing 2022-12-09 Share Issue/Capital Cha…
Country FR France
Listing PA LNA

About LNA Santé

https://www.lna-sante.com/

LNA Santé is a healthcare operator focused on providing care for vulnerable individuals. The company manages and operates a diverse network of facilities, including medicalized nursing homes that offer long-term care and specialized support for neurodegenerative diseases like Alzheimer's and Parkinson's. Its portfolio also includes Medical Care and Rehabilitation (SMR) establishments for post-acute and follow-up care, surgical clinics, and mental health clinics. In addition to its residential and outpatient facilities, LNA Santé provides hospital-at-home (HAD) services, delivering complex medical care directly to patients' residences. The organization's integrated approach serves individuals facing temporary or permanent loss of autonomy, disabilities, or the need for specialized medical treatment and rehabilitation.

Recent filings

Filing Released Lang Actions
LNA SANTE : RECTIFICATIF - Répartition de capital et des droits de vote attachés aux actions au 31/10/2022
Share Issue/Capital Change Classification · 95% confidence The document is a formal declaration from Société Générale regarding the breakdown of capital and voting rights as of October 31, 2022, referencing Article 223-16 of the AMF (Autorité des Marchés Financiers) General Regulation. This type of filing, which details the total number of shares, gross voting rights, and exercisable voting rights, is a specific regulatory disclosure related to share structure and ownership thresholds. It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV). It most closely aligns with a regulatory disclosure concerning share capital structure or major shareholding changes, although it is a routine update on total rights rather than a notification of a specific shareholder crossing a threshold. Given the options, it is a specific regulatory filing that doesn't fit the other precise categories like DIRS, DIV, or ER. It is a mandatory disclosure related to the capital structure. Since it is a specific regulatory disclosure that doesn't fit the other defined categories (like DIRS, DIV, ER, 10-K), and it is not an announcement of a report publication (RPA), the most appropriate general category for specific, non-standard regulatory disclosures is 'Regulatory Filings' (RNS). However, since it specifically details capital and voting rights, it is a very specific type of regulatory filing. Reviewing the definitions, 'Major Shareholding Notification' (MRQ) is for changes in significant ownership levels, which this document reports the basis for, but it is the total count itself. Given the highly specific nature of the content (capital and voting rights breakdown mandated by AMF), and the lack of a perfect fit, RNS (Regulatory Filings) serves as the best general regulatory disclosure bucket, although it is a very specific type of disclosure often related to share structure.
2022-12-09 French
LNA SANTE : DECLARATION DE TRANSACTIONS SUR ACTIONS PROPRES
Transaction in Own Shares Classification · 99% confidence The document is explicitly titled 'DECLARATION DE TRANSACTIONS SUR ACTIONS PROPRES' (Declaration of Transactions on Own Shares) and details the number of shares bought back, the weighted average price, and the total gross amount for specific dates between November 28 and December 2, 2022. This directly corresponds to the definition of a company reporting transactions in its own shares, which maps to the 'Transaction in Own Shares' category (POS). The document length is short (2064 chars), but it is a direct declaration, not an announcement of a report.
2022-12-06 French
LNA SANTE: Déclaration de transactions sur actions propres
Transaction in Own Shares Classification · 99% confidence The document is titled "DECLARATION DE TRANSACTIONS SUR ACTIONS PROPRES" (Declaration of Transactions on Own Shares) and details the number of shares bought back, the weighted average price, and the total gross amount for specific dates (November 23 to 25, 2022). This directly corresponds to the definition of a report detailing the company buying back or selling its own shares. The appropriate filing code is POS (Transaction in Own Shares). The document is a direct report of the transaction, not an announcement of a report, and its content is highly specific.
2022-11-28 French
LNA SANTE : MISE EN OEUVRE DU PROGRAMME DE RACHAT D’ACTIONS PROPRES
Transaction in Own Shares Classification · 100% confidence The document is titled "MISE EN ŒUVRE DU PROGRAMME DE RACHAT D'ACTIONS PROPRES" (Implementation of the Share Buyback Program) and details a mandate given to an investment service provider to acquire a maximum of 250,000 shares for cancellation. This directly relates to the company purchasing its own shares. According to the definitions, this corresponds to 'Transaction in Own Shares' (Code: POS). The document is short and serves as an announcement of this specific corporate action.
2022-11-23 French
LNA SANTE: Chiffre d'Affaires du 3ème trimestre 2022
Earnings Release Classification · 98% confidence The document is a press release dated November 8, 2022, detailing the financial results for the 'Troisième trimestre 2022' (Third Quarter 2022) and the '9 mois' (9 months) period. It presents key financial figures (Chiffre d'affaires Exploitation), operational metrics (taux d'occupation), management commentary, and confirms annual outlooks. This structure—a concise announcement of period results with key highlights—is characteristic of an Earnings Release (ER). It is not the full, comprehensive annual report (10-K) or a detailed interim report (IR), but rather the initial release of quarterly performance data. Q3 2022
2022-11-08 French
LNA Santé: répartition de capital et des droits de vote attachés aux actions au 31/10/2022
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Déclaration au titre de l'article 223-16 du règlement général de l'Autorité des Marchés Financiers" and provides the "Répartition de capital et des droits de vote attachés aux actions au 31/10/2022" (Capital and voting rights breakdown as of October 31, 2022). This type of mandatory disclosure, detailing the total number of shares and voting rights, is typically associated with regulatory reporting concerning capital structure and ownership thresholds. While it relates to capital, it is specifically a declaration about the total voting rights count, which is a common component of regulatory filings or specific capital structure updates. Given the options, it most closely aligns with a general regulatory filing or a specific capital/share announcement. Since it is a formal declaration of the total capital and voting rights structure, it fits best under a general regulatory filing category (RNS) or potentially a specific capital change/share announcement (SHA). However, the core content is a mandatory regulatory disclosure about the capital base and voting rights, which often falls under general regulatory reporting requirements in many jurisdictions. Given the specific nature of reporting total voting rights, and lacking a dedicated 'Voting Rights Disclosure' code, RNS (Regulatory Filings) is the most appropriate fallback for this specific regulatory declaration that isn't a standard financial report (10-K, IR) or a dividend/share issue announcement (DIV, SHA). The document length is short, but it is the primary disclosure, not an announcement of another report.
2022-11-08 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.